Mirabella Financial Services LLP purchased a new stake in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,550,000 shares of the company's stock, valued at approximately $18,383,000. Core Scientific makes up about 1.2% of Mirabella Financial Services LLP's holdings, making the stock its 21st biggest position. Mirabella Financial Services LLP owned about 0.56% of Core Scientific at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Dynamic Technology Lab Private Ltd grew its holdings in shares of Core Scientific by 48.8% during the third quarter. Dynamic Technology Lab Private Ltd now owns 34,786 shares of the company's stock worth $413,000 after buying an additional 11,412 shares in the last quarter. Pekin Hardy Strauss Inc. grew its stake in shares of Core Scientific by 25.4% during the 3rd quarter. Pekin Hardy Strauss Inc. now owns 30,725 shares of the company's stock worth $364,000 after acquiring an additional 6,225 shares in the last quarter. Seldon Capital LP acquired a new stake in shares of Core Scientific in the third quarter valued at approximately $3,530,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Core Scientific by 44.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,932,462 shares of the company's stock valued at $22,919,000 after purchasing an additional 590,946 shares during the last quarter. Finally, Highland Peak Capital LLC lifted its position in shares of Core Scientific by 37.9% in the third quarter. Highland Peak Capital LLC now owns 413,584 shares of the company's stock worth $4,905,000 after purchasing an additional 113,584 shares in the last quarter.
Core Scientific Stock Performance
Shares of NASDAQ CORZ traded down $0.12 during midday trading on Monday, reaching $18.11. The company's stock had a trading volume of 8,897,813 shares, compared to its average volume of 8,912,980. The company has a market cap of $5.06 billion and a P/E ratio of -3.37. Core Scientific, Inc. has a fifty-two week low of $2.61 and a fifty-two week high of $18.51. The business's 50 day moving average price is $13.67 and its two-hundred day moving average price is $10.42.
Insiders Place Their Bets
In other Core Scientific news, insider Todd M. Duchene sold 25,000 shares of the stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $17.10, for a total transaction of $427,500.00. Following the sale, the insider now directly owns 1,661,474 shares in the company, valued at $28,411,205.40. This represents a 1.48 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Yadin Rozov sold 105,000 shares of the firm's stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the completion of the transaction, the director now directly owns 345,239 shares in the company, valued at approximately $6,252,278.29. This represents a 23.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased a total of 12,761 shares of company stock worth $127,080 in the last 90 days.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $20.00 price target on shares of Core Scientific in a research note on Thursday, October 3rd. Needham & Company LLC lifted their target price on Core Scientific from $17.00 to $18.00 and gave the company a "buy" rating in a research report on Thursday, November 7th. Macquarie increased their price target on Core Scientific from $16.00 to $19.00 and gave the company an "outperform" rating in a research report on Thursday, November 14th. BTIG Research raised their price target on Core Scientific from $15.00 to $19.00 and gave the company a "buy" rating in a research note on Friday, November 15th. Finally, Canaccord Genuity Group started coverage on Core Scientific in a report on Monday, September 23rd. They issued a "buy" rating and a $16.00 price objective for the company. Thirteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Core Scientific presently has a consensus rating of "Buy" and a consensus target price of $18.38.
View Our Latest Research Report on CORZ
Core Scientific Profile
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Featured Stories
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.